Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1992-03-31
1993-06-15
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514725, 514824, A61K 3120, A61K 3107
Patent
active
052198880
ABSTRACT:
A method to increase plasma high density lipoprotein levels for the treatment and prevention of coronary artery disease by administering a therapeutic amount of a retinoid of the general formula: ##STR1##
REFERENCES:
Widom et al., Mol. Cell Biol., 12:3380-3389 (1992).
Widom et al., Mol. Cell Biol., 11:677-687 (1991).
Miller, N. E., Am. Heart J. 113:589-597 (1987).
Eisenberg, S., J. Lipid Res. 25:1017-1058 (1984).
Brattsand, Atherosclerosis, vol. 22, 1975, pp. 47-61.
Pawson et al., J. Med. Chem. 25: 1269-1277 (1982).
Rottman et al., Mol. Cell Biol., 11: 3814-3820 (1991).
Ringer et al., Am. J. Clin. Nutr., 53: 688-694 (1991).
Lyons et al., Br. J. Dermatology, 107: 591-595 (1982).
Karathanasis Sotirios K.
Katocs, Jr. Andrew S.
Largis Elwood
American Cyanamid Company
Dow Kenneth J.
Jordan Kimberly R.
Waddell Frederick E.
LandOfFree
Use of retinoids for the treatment of coronary artery disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of retinoids for the treatment of coronary artery disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of retinoids for the treatment of coronary artery disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1043138